山德士（中国）制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
17
NMPA:17
Drug Approvals
Diclofenac Sodium Sustained Release Tablets(IV)
- Product Name
- 迪克乐克
- Approval Number
- 国药准字H10980037
- Approval Date
- Jul 30, 2020
NMPA
Isosorbide Mononitrate Sustained-release Tablets
- Product Name
- 单硝酸异山梨酯缓释片
- Approval Number
- 国药准字H20046357
- Approval Date
- Jul 27, 2020
NMPA
Tramadol Hydrochloride Sustained Release Tablets
- Product Name
- 泰德洛
- Approval Number
- 国药准字H20030564
- Approval Date
- Jul 10, 2020
NMPA
Ambroxol Hydrochloride Tablets
- Product Name
- 安普索
- Approval Number
- 国药准字H19990228
- Approval Date
- Jun 15, 2020
NMPA
Isosorbide Mononitrate Sustained Release Tablets
- Product Name
- 索尼特
- Approval Number
- 国药准字H10980015
- Approval Date
- Jun 11, 2020
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20093672
- Approval Date
- Sep 27, 2019
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found